Clinical Trials in Philadelphia

Showing 10661-10680 of 20,904 trials

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

NCT04411628

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it. Participation could last about 8 weeks and may include up to 15 visits in the hospital or the home.

COVID-19

Eli Lilly and Company26 participantsStarted May 2020

Los Angeles, California, United States • San Diego, California, United States • Atlanta, Georgia, United States +8 more locations

COMPLETEDPhase 1< 1 mile

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

NCT01922752

The primary objective is to determine the maximum tolerated dose (MTD), safety, and tolerability of oral CEP-37440 administered daily to patients with advanced or metastatic solid tumors.

Solid Tumors

Teva Branded Pharmaceutical Products R&D, Inc.32 participantsStarted Jul 2013

Chicago, Illinois, United States • Philadelphia, Pennsylvania, United States • San Antonio, Texas, United States

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Find Trials by Condition in Philadelphia

Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors

Internet-based CBT After Stroke Pilot

Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)

Aim to Reduce Movements in Tardive Dyskinesia

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Addressing Involuntary Movements in Tardive Dyskinesia

Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling

Addressing Barriers to Adult Hearing Healthcare

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects